Identity
- Security key
- 11475
- Ticker
- AIDX
- Type
- CS — Common Stock
- Exchange
- Nasdaq(XNAS)
- Venue group
- NASDAQ
- Operating MIC
- XNAS
- Market
- stocks
- Locale
- us
- Currency
- USD
- Listed
- 2026-02-19
- Round lot
- 100
- Active
- Yes
- Last seen in a load
- 2026-08-14 20:49
- Vendor updated
- 2026-08-13 06:09
- Ticker root / suffix
- AIDX
Detail
Enriched 2026-08-14 20:47
- Market cap
- $5,647,802.28
- Shares outstanding (class)
- 12,251,198
- Shares outstanding (weighted)
- 12,251,198
- SIC
- 8734 SERVICES-TESTING LABORATORIES
- Employees
- 14
- Location
- ROCKVILLE, MD
- Homepage
- https://www.2020biolabs.com
- Description
20/20 Biolabs Inc is a commercial stage diagnostics company with the core mission of developing and commercializing clinical laboratory tests for early disease detection and prevention and associated software that is powered by machine learning and real-world data to improve diagnostic accuracy and clinical utility. The company offers two OneTest lab products; OneTest for Cancer that inludes primary MCED blood test and revenue source post-COVID and OneTest for Longevity that consists of inflammatory biomarkers.
Market cap and share counts drift.